Go ahead – talk about your prostate. Real men know that spreading the word about lifesaving screenings and treatment options saves lives. Get regular exams and encourage other men to do the same.
Prostate cancer is the most frequently diagnosed cancer in men and second-leading cause of cancer death in men. It is not something that just affects older men, men of a certain race, or men who do not exercise. That is why it is vitally important that all men see their doctor for annual prostate exams and physicals. Through screenings and early diagnosis, you can increase your chance of surviving prostate cancer.
Indiana University Health Cancer Centers offer the latest in prevention, detection and treatment of prostate cancer. Our multidisciplinary team consists of national and international leaders in prostate cancer care and research. You have assurance that our highly skilled physicians, nurses, dietitians, physical therapists, spiritual care chaplains, social workers and pharmacists will work with you and your loved ones to develop the best course of treatment for your illness.
We are home to Indiana's largest network of geographically diverse cancer specialists with expertise in medical, radiation and surgical oncology. With a strong emphasis on translating research to clinical application, IU Health Cancer Centers turn development and participation in cutting edge clinical trials into real results. Whether you are newly diagnosed, or well on the road to recovery, count on IU Health Cancer Centers for the best in prostate cancer care.
The prostate, a small organ that exists only in men, is located just below the bladder and surrounds the urethra, which carries urine out of the body. Prostate cancer forms from the cells that normally produce prostate secretions, which are important for fertility. Like other cancers, prostate cancer begins when some damaged cells begin to grow out of control. Unlike normal cells, which live for a time and then die in the body's natural renewal process, cancerous cells live beyond their normal life and begin to crowd out healthy tissue. It's important to note that not all prostate cancers are the same. Many grow slowly and do not cause harm, while some grow fast and cause serious health problems or death.
Prostate cancer can cause the prostate to swell and obstruct the urethra, making urination difficult. However, most men that are having urination problems are suffering from non-cancerous enlargement, typically referred to as prostate hypertrophy. In addition, the absence of urinary symptoms does not exclude the presence of prostate cancer. Therefore, it's extremely important to discuss with your physician if you are experiencing urination problems and to have regular screenings, even if you are not experiencing symptoms, to determine your diagnosis.
All men diagnosed with prostate cancer want access to the most advanced treatments available. IU Health Cancer Centers have extensive experience treating all stages of prostate cancer, and offers the most innovative treatment options at one of our IU Health Cancer Centers locations, our IU Health Central Indiana Cancer Center's outpatient locations and the Indiana University Health Proton Therapy Center.
IU Health Cancer Centers’ commitment to research and advances in prostate cancer prevention and treatment distinguishes our program from other cancer centers. We perform many clinical trials to test new drugs and other treatments that may be more effective than currently accepted screening, diagnosis or treatments of prostate cancer. Depending on your diagnosis, you may have access to one or more of these trials.
We have also developed extensive research collaborations with researchers at Indiana University School of Medicine, Indiana University and Purdue University. Through the development of these collaborations, we can bring our patients the best that research and expert clinical care can offer.
More information about cancer research can be found on the IU School of Medicine website.
Getting screened for prostate cancer is as simple as making an appointment with your physician. Prostate cancer can cause blood in your urine, difficulty passing urine or pain during urination. However, most men will never experience any symptoms. Therefore, it is important to receive regular screenings by your physician.
Screening, when performed in conjunction with careful discussion between patient and physician, is recommended in men aged 55 to 69 in alternating years/ every two years. Men under 55 who have risk factors for developing prostate cancer should discuss the benefits of earlier screening with their physician. This includes men with a family history of prostate cancer and those of African American descent. The majority of men over 70, or those with a life expectancy of less than 10 to 15 years, will not benefit from routine screening.
A PSA test is the most common type of prostate cancer screening test, measuring the blood level of PSA, a protein produced by your prostate gland. In general, a higher level of PSA equals a greater chance of developing prostate cancer. However, other factors can cause an elevated PSA level and, more importantly, some men with prostate cancer may not even have an elevated level of PSA. Therefore, it is important to talk to your doctor about your screening options.
If your initial screening shows a possibility of prostate cancer, you may need further testing including biopsy of the prostate tissue to determine if cancer is present.
Prostate Cancer Treatment
Bone marrow and stem cell transplant
- Thyroid, adrenal cortex, and pancreas cancers
- Colon, rectum, appendix, bile duct, esophagus, gallbladder, liver, pancreas, small intestine, and stomach cancers
- Prostate, bladder, kidney, penis, and ureter cancers
- Cervix, ovary, uterus, vulva, and vagina cancers
Head and neck cancers
Hematology and hematologic malignancies
- Leukemia, lymphoma and myeloma
- Liver, pancreas, and gall bladder cancers
- Brain, spinal cord, and metastatic nervous system tumors
- Soft tissue lesions and metastatic bone cancers
Skin cancer and melanoma
- Lung, esophagus, pleura, and chest wall cancers
- Thymus gland cancer
Prostate Cancer Innovation
Lawrence Einhorn, MD, of the IU Health Simon Cancer Center researchers and physicians helped improve the cure rate of testicular cancer from 10 percent to nearly 95 percent today.
A study led by Doug Schwartzentruber, MD, at IU Health Goshen Center for Cancer Care was one of the first to demonstrate that therapeutic vaccines may have a benefit against cancer.
The Pancreatic Cyst and Cancer Early Detection Center led by C. Max Schmidt, MD, is the largest of its kind, treating more than 1,000 patients at-risk for pancreatic cancer to identify means of early detection and treatment.
Research conducted by Bryan Schneider, MD, of the IU Health Simon Cancer Center that identified a genetic biomarker that causes neuropathy among some breast cancer patients using certain chemotherapy drugs was named one of the top clinical research advances of 2011 by the American Society of Clinical Oncology.
Robotic Assisted Imaging
Emma Rossi, MD, was the first to describe the use of robotic assisted near infrared imaging to map sentinel lymph nodes for endometrial and cervical cancers.